Correlation assessment of Perfusion quantification with Fluobeam and operative outcome in prepectoral implant breast reconstruction: single center, open, prospective observational study

Seoul National University Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新: 2022年3月8日

试验速览

暂无简介。

•All patients can participate in this study only if they meet all of the following criteria.
•(1) Patients over 19 years of age
•(2) Patients who need total mastectomy for breast cancer
•(3) Patients undergoing immediate two-stage implant breast reconstruction after total mastectomy (skin preservation) is performed.
•(4) Patients who use Acelluar Dermal Matrix for breast reconstruction
•(5) Patients who need radiotherapy after breast reconstruction
•(6) Patients who agree to participate in the study and can be followed up within the study period

•Patients with any of the following criteria were excluded from this study.
•(1) A patient undergoing chemotherapy for cancer other than breast cancer
•(2) Patients with confirmed local recurrence or systemic metastasis of breast cancer
•(3) Patients with underlying conditions such as infectious diseases, systemic autoimmune diseases (especially rheumatoid diseases, etc.), and blood coagulation disorders
•(4) Patients with systemic diseases other than breast cancer
•(5) Pregnant women or lactating women
•(6) Other patients who were judged to be difficult to participate in this study by the investigator

发起方